Franklin Strategic Real Return Fund OCSE:NOVO B Holdings History
Franklin Strategic Real Return Fund's Novo Nordisk AS Holding Summary
As of 2024-03-31, Franklin Strategic Real Return Fund held 2,967.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr380,590.00. This investment constitutes 0.99% of their stock portfolio, and Franklin Strategic Real Return Fund now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2020Q1. And since then Franklin Strategic Real Return Fund has made 1 purchases of OCSE:NOVO B, at an average price of kr202.33, for a total of 4,300.00 shares. In addition, there have been 4 sales at an average price of kr471.94 for 1,333.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr442.80, Franklin Strategic Real Return Fund's estimated gain on his OCSE:NOVO B holdings is kr1.07 Mil, reflecting a 123.32% gain to date.
Franklin Strategic Real Return Fund OCSE:NOVO B (kr442.80) Holding Chart
Franklin Strategic Real Return Fund OCSE:NOVO B (kr442.80) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
